Lenskart Listed
Lenskart is an Indian, vertically integrated omnichannel eyewear company that designs, manufactures, distributes and retails prescription eyeglasses, sunglasses, contact lenses and accessories through its website, mobile app and a 2,700+ store network across India and overseas markets. It listed on the NSE and BSE on November 10, 2025, after a ₹7,278 crore (~$828M) IPO.
Valuation
Returns
Per share
Growth · year on year
Ownership
Price and ratios are compiled from the exchange and third-party market data, cached and refreshed through the day — they are not Atlas facts and are not investment advice. Where a ratio is computed on more than one basis (for example standalone versus trailing-twelve-month), each is shown separately rather than averaged into a single number.
How this score is calculated
| Measure | Value | Scores | Source |
|---|---|---|---|
| P/E What the market pays for each rupee of earnings. Lower is cheaper — but a low P/E can also mean the market expects earnings to fall. Computed on a different basis this reads 227.81, which would score 0/100. Scored on the figure shown. |
137.66 | 0/100 | BSE |
| P/B Price against book value. Most meaningful for banks and asset-heavy businesses; software and consumer brands trade high here for good reasons. |
12.89 | 0/100 | Market data |
| ROE Return on equity — profit generated per rupee of shareholder capital. Sustained high ROE is the clearest single marker of a good business. |
6.17 | 25/100 | Market data |
| ROCE Return on capital employed — the same idea including debt, so it is harder to flatter with leverage. |
9.72 | 25/100 | Market data |
| Profit growth Year-on-year growth in profit. Weighted above sales growth because profitable growth is the harder thing to do. |
153.03 | 100/100 | Market data |
| Sales growth Year-on-year growth in revenue. |
29.92 | 100/100 | Market data |
| Promoter holding How much of the company its founders and controlling group still own. Higher usually means their money moves with yours. |
17.53 | 25/100 | Market data |
The Atlas Score is our own arithmetic on the published figures above — nothing is hidden and nothing is bought in. It weighs quality and growth at 30% each, valuation at 25% and ownership at 15%, scoring each measure against fixed bands. Growth blends third-party market data with the fiscal-year figures we file and cite ourselves, so a company we have researched more deeply scores on richer evidence. A measure we could not fetch is left out of the average rather than counted as a zero. It is a summary of the numbers, not a recommendation, not a price target, and not advice about your circumstances.
Lenskart: Funding Rounds
| Date | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 3 Jun 2024 | Secondary | $200M | Temasek Fidelity | source |
| 14 Jun 2023 | Primary + Secondary | $100M | ChrysCapital | source |
| 6 Jul 2022 | Growth (Series H) | $200M | Alpha Wave Global Avendus Future Leaders Fund II Epiq Capital | source |
| 18 Jul 2021 | Growth (Series) | $220M | Temasek Bay Capital Chiratae Ventures Falcon Edge Capital | source |
| 16 May 2021 | Secondary | $95M | KKR | source |
| 20 Dec 2019 | Series G | $275M | SoftBank Vision Fund | source |
| 16 Sep 2019 | Series F | $55M | Kedaara Capital | source |
| 7 Sep 2016 | Series D (extension) | ~₹200 Cr (~$30M) | PremjiInvest | source |
| 5 May 2016 | Series D | $60M (₹400 Cr) | International Finance Corporation (IFC) Adveq Management Chiratae Ventures Kris Gopalakrishnan Ratan Tata TPG Growth | source |
| 1 Jan 2015 | Series C | $22M (₹135 Cr) | TR Capital Chiratae Ventures TPG Growth | source |
| 1 Dec 2012 | Series B | $10M | Unilazer Ventures Chiratae Ventures | source |
| 31 Oct 2011 | Series A | $4M | Chiratae Ventures | source |
Acquisitions
Recent Signals
News on Lenskart
-
29 Aug 2026
Lenskart ₹1,857 Crore Deal: Goldman Sachs, Morgan Stanley Among Buyers -
28 Aug 2026
Lenskart Stake Sale: Alpha Wave to Sell ₹1,313 Crore Holding -
25 Aug 2026
Lenskart investors sell over $1 Billion worth stake in 3 months -
24 Aug 2026
SoftBank sell 2.58% Lenskart Stake for ₹2,888 Crore, Holding Falls to 7.28% -
22 Aug 2026
Lenskart Stake Sale: SoftBank Plans $300M Block Deal -
18 Aug 2026
Lenskart Stock Rises 4.5% On China Expansion Plans -
13 Aug 2026
Lenskart Adds 116 India Stores in Q1 as Digital Influence Reaches 55% of Revenue -
12 Aug 2026
Lenskart Profit Jumps 3.7X to ₹228 Crore in Q1, Revenue Grows 34% -
29 Jul 2025
Lenskart Turns Profitable in FY25 With ₹297 Crore Net Profit -
14 Jul 2026
Temasek offloads 2% stake in Lenskart for Rs 1,945 crore -
12 Jun 2026
ADIA trust sell 2.3% stake in Lenskart worth Rs 1,960 Cr -
4 Jun 2026
SoftBank sell Lenskart shares worth Rs 2,873 cr
L Litmus · by Lapaas
See the full business-model breakdown and validation framework for this company.
View Litmus AnalysisFAQs on Lenskart
Who founded Lenskart?
Lenskart was founded by Peyush Bansal, Amit Chaudhary, Sumeet Kapahi, Neha Bansal in 2010.
How much funding has Lenskart raised?
Lenskart has raised $876 Mn across 12 tracked funding round(s), most recently on 2024-06-03. Figures are compiled from cited public sources.
Who are the investors in Lenskart?
Investors in Lenskart include Temasek, Fidelity, ChrysCapital, Alpha Wave Global, Avendus Future Leaders Fund II, Epiq Capital.
What does Lenskart do?
Lenskart is an Indian, vertically integrated omnichannel eyewear company that designs, manufactures, distributes and retails prescription eyeglasses, sunglasses, contact lenses and accessories through its website, mobile app and a 2,700+ store network across India and overseas markets. It listed on the NSE and BSE on…
Where is Lenskart headquartered?
Lenskart is headquartered in Gurugram, Haryana, India.
What is Lenskart's business model?
Lenskart's core value proposition centers on Affordable eyewear through vertical integration, Premium private-label fashion eyewear, Convenience: eye test and try-on at home or in-store.
How does Lenskart make money?
Lenskart's cited revenue streams include Product sales (eyewear, sunglasses, contact lenses, accessories), Services (memberships, home eye check-ups, training), Other operating income.